Tech Company Financing Transactions
AcelRx Pharmaceuticals Funding Round
AcelRx Pharmaceuticals secured a $14.8 million funding round on 12/31/2009. Investors included Alta Partners and Three Arch Partners.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$14,814,000
Round
Undisclosed
Investors
Alta Partners (Guy Nohra)
Three Arch Partners (Mark Wan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
351 Galveston Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
AcelRx Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the conceptualization, research, development, and commercialization of novel treatments for the management of painful conditions where currently available treatments are not optimal.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vincent Angotti
Chief Financial Officer
Raffi Asadorian
Chief Medical Officer
Pamela Palmer
VP - Bus. Development
Larry Hamel
VP - Engineering
Badri Dasu
Browse more venture capital transactions:
Prev: 12/31/2009: PayScale venture capital transaction
Next: 12/31/2009: Corventis venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs